ResMed, Inc. (RMD)

250.92 +2.71 (+1.09%) USD  |  NYSE  |  Jan 08, 16:00
254.40 +3.48 (+1.39%) Pre-Market: 20:00
More

ResMed Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for RMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Boston Scientific Corp. Upgrade
Abbott Laboratories Upgrade
Stryker Corp. Upgrade
Becton, Dickinson & Co. Upgrade
West Pharmaceutical Services, Inc. Upgrade